Overview Japanese Phase 1 Multiple Ascending Dose Study Status: Completed Trial end date: 2012-09-01 Target enrollment: Participant gender: Summary The purpose of this clinical study is to assess the safety and tolerability of multiple oral doses of BMS-823778 in healthy Japanese subjects and Japanese patients with Type 2 Diabetes Mellitus. Phase: Phase 1 Details Lead Sponsor: Bristol-Myers Squibb